Marketing-authorisation holder · United States
Zydus Pharms
66 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
66 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 66
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACYCLOVIR200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG | 800MG · Tablet | Aciclovir | United States | Marketed | 1997 |
| ACYCLOVIR SODIUM1gm base/vial | 25mg base/ml | 500mg base/vial | 50mg base/ml · Injectable | Aciclovir | United States | Marketed | 1997 |
| ALBENDAZOLE200mg · Tablet | Albendazole | United States | Marketed | 2018 |
| AMANTADINE HYDROCHLORIDE68.5mg base · Capsule, extended release | Amantadine | United States | Not marketed | 2024 |
| AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE10mg; 20mg | 10mg; 40mg | 2.5mg; 10mg | 5mg; 10mg | 5mg; 20mg · Capsule | Amlodipine, Benazepril | United States | Marketed | 2011 |
| APALUTAMIDE60mg · Tablet | Apalutamide | United States | Marketed | 2025 |
| ASPIRIN AND DIPYRIDAMOLE25mg; 200mg · Capsule, extended release | Acetylsalicylic acid, Dipyridamole | United States | Marketed | 2009 |
| ATENOLOL AND CHLORTHALIDONE100mg; 25mg | 50mg; 25mg · Tablet | Atenolol, Chlorthalidone | United States | Marketed | 1990 |
| BROMOCRIPTINE MESYLATE5mg base · Capsule | Bromocriptine | United States | Marketed | 1998 |
| CARBIDOPA25mg · Tablet | Carbidopa | United States | Marketed | 2014 |
| CLINDAMYCIN HYDROCHLORIDE150mg base | 300mg base | 75mg base · Capsule | Clindamycin | United States | Marketed | 1989 |
| CLOBETASOL PROPIONATE0.05% · Spray | Clobetasol | United States | Marketed | 2011 |
| CLOMIPRAMINE HYDROCHLORIDE25mg | 50mg | 75mg · Capsule | Clomipramine | United States | Marketed | 1996 |
| DEFERASIROX125mg | 250mg | 500mg · Tablet, for suspension | Deferasirox | United States | Marketed | 2016 |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)0.01mg/spray · Spray, metered | Desmopressin | United States | Marketed | 2005 |
| DESVENLAFAXINE SUCCINATE100mg base | 25mg base | 50mg base · Tablet, extended release | Desvenlafaxine | United States | Marketed | 2015 |
| DICLOFENAC SODIUM AND MISOPROSTOL50mg; 0.2mg | 75mg; 0.2mg · Tablet, delayed release | Diclofenac, Misoprostol | United States | Marketed | 2012 |
| DILTIAZEM HYDROCHLORIDE120mg | 180mg | 240mg | 300mg | 360mg | 420mg | 60mg | 90mg · Capsule, extended release | Diltiazem | United States | Marketed | 1993 |
| DIROXIMEL FUMARATE231mg · Capsule, delayed release | Diroximel fumarate | United States | Marketed | 2025 |
| DIVALPROEX SODIUM250mg valproic acid | 500mg valproic acid · Tablet, extended release | Divalproex | United States | Marketed | 2009 |
| DOXYCYCLINE100mg base/vial | 200mg base/vial · Injectable | Doxycycline | United States | Marketed | 1983 |
| DOXYCYCLINE100mg base | 150mg base | 50mg base | 75mg base · Tablet | Doxycycline | United States | Marketed | 2000 |
| DOXYCYCLINE100mg base | 150mg base | 40mg | 50mg base | 75mg base · Capsule | Doxycycline | United States | Marketed | 2000 |
| DOXYCYCLINE HYCLATE100mg base | 120mg base | 150mg base | 200mg base | 50mg base | 60mg base | 75mg base | 80mg base · Tablet, delayed release | Doxycycline | United States | Marketed | 2010 |
| DROXIDOPA100mg | 200mg | 300mg · Capsule | Droxidopa | United States | Marketed | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 66 | 52 | 14 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.